AIG
AST.WS

American International Group’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

American International Group’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,222
Closed -$1K – 3101
2017
Q2 		$1K Sell
1,222
-1
-0.1% – ﹤0.01% 3075
2017
Q1 		$1K Hold
1,223
– – ﹤0.01% 2998
2016
Q4 		$1K Hold
1,223
– – ﹤0.01% 3000
2016
Q3 		$624 Hold
1,223
– – ﹤0.01% 3029
2016
Q2 		$245 Buy
+1,223
New +$637 ﹤0.01% 3082

American International Group's AST.WS Position: Q3 2017 in Review

American International Group sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 1,222 shares — an estimated $1K sold.

American International Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $1K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • American International Group reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • American International Group sold 1,222 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $1K.
  • American International Group first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • American International Group's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $1K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on American International Group's 13F filing for Q3 2017, filed 9 Nov 2017.